Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

  1. Baron, F.
  2. Labopin, M.
  3. Peniket, A.
  4. Jindra, P.
  5. Afanasyev, B.
  6. Sanz, M.A.
  7. Deconinck, E.
  8. Nagler, A.
  9. Mohty, M.
Revue:
Cancer

ISSN: 1097-0142 0008-543X

Année de publication: 2015

Volumen: 121

Número: 7

Pages: 1048-1055

Type: Article

DOI: 10.1002/CNCR.29163 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable